Skip to main content

3 Result(s)

within Richard M. ** Remove this filter Dutch Remove this filter

and

  1. No Access

    Article

    20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR)

    Activation of the sympathetic nervous system through substance P via DPP-4 inhibition (DPP-4i) in the presence of higher dose ACE inhibition (ACEi) has led to hypothetical concerns of the cardiovascular (CV) s...

    Dr. E.H. (Erik) Serné, William B. White… in Nederlands Tijdschrift voor Diabetologie (2015)

  2. No Access

    Article

    14. Glycemic control and hypoglycemia with new insulin glargine 300 U/mL in people with T1DM (EDITION 4) (80-LB (late breaking))

    EDITION 4 studied the efficacy and safety of new insulin glargine (300 U/mL; Gla-300) vs glargine 100 U/mL (Gla-100) in people with T1DM. In this 6-month, multinational, multicenter, open-label study, particip...

    Philip D. Home, Richard M. Bergenstal… in Nederlands Tijdschrift voor Diabetologie (2014)

  3. No Access

    Article

    7.4 Improved Glycemic Control Despite Reductions in Bolus Insulin Doses with Basal Insulin LY2605541 Compared with Basal Insulin Glargine in Patients with Type 1 Diabetes (915-P)

    LY2605541 (LY) is a novel basal insulin analog with a prolonged duration of action. The objective of this analysis was to further explore the initial observation of a reduction in prandial insulin requirements...

    Julio Rosenstock, Richard M. Bergenstal… in Nederlands Tijdschrift voor Diabetologie (2013)